These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1907949)

  • 21. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A rare etiology for HBs-Ag negative acute hepatitis B--coinfection by hepatitis B and delta].
    Körner T; Jaspersen D; Roth J; Hammar CH; Bässler R
    Leber Magen Darm; 1994 Sep; 24(5):215-7. PubMed ID: 7968181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 25. [IgM antibodies against hepatitis B core antigens, anti-HBc-IgM. Their diagnostic significance].
    Esteban R; Guardia J; Buti M; Esteban JI; Rodrigo MJ; Jardí R; Hernández JM; Bacardí R
    Med Clin (Barc); 1984 Oct; 83(11):437-9. PubMed ID: 6503413
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological pattern of hepatitis B virus markers (HBsAg, anti-HBs, IgM anti-HBc and HBV specific DNA polymerase) in leprosy patients.
    Moudgil KD; Irshad M; Gandhi BM; Mishra R
    Indian J Lepr; 1989 Jan; 61(1):54-60. PubMed ID: 2649622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Viral infection markers in foci of chronic hepatitis B].
    Nechaev VV; Mikhaĭlov MI; Mukomolov SL; Shliakhtenko LI; Zubov SV
    Vopr Virusol; 1988; 33(5):554-8. PubMed ID: 2975430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis with isolated serum antibody to hepatitis B core antigen. A variant of non-A, non-B hepatitis?
    Lai KN; Lai FM; Leung NW; Lo ST; Tam JS
    Am J Clin Pathol; 1990 Jan; 93(1):79-83. PubMed ID: 2104740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs.
    Wu JS; Chen CH; Chiang YH; Lee YC; Lee MH; Ko YC; Hu HT
    Taiwan Yi Xue Hui Za Zhi; 1980 Sep; 79(9):760-7. PubMed ID: 6939789
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population.
    Kroes AC; Quint WG; Heijtink RA
    J Med Virol; 1991 Oct; 35(2):96-100. PubMed ID: 1765777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HBs, HBc, and HBe antigens and their respective antibodies].
    Akabane Y
    Nihon Rinsho; 1979 Jun; Suppl():2407-8. PubMed ID: 491169
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of HBs antigen negative fulminant hepatitis with IgM antibody to hepatitis B core antigen persisting more than seven years.
    Suga M; Shibata K; Kodama T; Arima K; Yamada S; Yachi A
    Gastroenterol Jpn; 1991 Oct; 26(5):661-5. PubMed ID: 1752398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of hepatitis B antigen (HBsAg) and its related antibody (anti-HBs) in acute viral hepatitis].
    Giuliani G; Castelletti GC; Novara O; Paggi GC; Varetti G; Grillone W; Bosio G; Aggero S
    G Batteriol Virol Immunol; 1977; 70(7-12):197-214. PubMed ID: 615745
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the etiology and course of acute virus hepatitis: analysis of HBs-antigens, anti-HBc, EBV and CMV antibodies].
    Heissmeyer H; Berthold H; Schmitz H; Lönngren G; Gerok W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():550-2. PubMed ID: 206062
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of an enzyme-immunoassay with a radio-immunoassay method for the detection of the hepatitis markers anti-HBs, anti-HBc and HBsAg.
    Blackburn NK; Schoub BD; O'Connell KF
    S Afr Med J; 1990 Jul; 78(2):102-3. PubMed ID: 2196700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic significance of anti-HBc IgM (RIA) in healthy HBsAg carriers and in chronic hepatitis B.
    Surrenti C; Ambu S; Patussi V; Milani S; Casini A; Zacchi P; Ceccatelli P; Cefaratti C; D'Agata A
    J Med Virol; 1986 Mar; 18(3):229-34. PubMed ID: 3701301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver disease in anti-HBe positive chronic HBsAg carriers and hepatitis C virus.
    Fattovich G; Tagger A; Brollo L; Pontisso P; Realdi G; Perroni P; Alberti A
    Lancet; 1989 Sep; 2(8666):797-8. PubMed ID: 2571028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical significance of hepatitis B virus markers ].
    Iino S
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):992-6. PubMed ID: 2230488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.